| http://www.w3.org/ns/prov#value | - The evidence related to the use of SBRT for the management of oligometastases to multiple sites, including the lungs, liver, adrenal glands, and bones (other than spine) consists of relatively small, noncomparative studies, and there is a lack of consensus about optimal dose, fractionation, and the size, number, and types of lesions amenable to SBRT. Clinical input was mixed regarding the use of S
|
